U.S. Markets closed

Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against TG Therapeutics, Inc.

OKLAHOMA CITY--(BUSINESS WIRE)--

On October 4, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc. (TGTX). Federman & Sherwood reminds current and former shareholders of TG Therapeutics, Inc. that they only have until Monday, December 3, 2018 to move the court for appointment as a lead plaintiff in this case. The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you purchased TG Therapeutics, Inc. shares between June 4, 2018 and September 25, 2018, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible. Our firm seeks to recover damages on behalf of the Class. Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud. We represent investors throughout the country in shareholder litigation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181119005600/en/